ProMIS Neurosciences releases updated corporate presentation; no material new data disclosed

ProMIS Neurosciences Inc.

Presentation dated January 27, 2025, posted to company website.
Targets neurodegenerative disease with focus on misfolded proteins.
No specific financial results, guidance, or pipeline milestones disclosed.
Filed as Regulation FD disclosure; not incorporated by reference.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.